QRG Capital Management Inc. Grows Holdings in Integer Holdings Co. (NYSE:ITGR)

QRG Capital Management Inc. increased its stake in Integer Holdings Co. (NYSE:ITGR) by 3.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 36,938 shares of the medical equipment provider’s stock after buying an additional 1,374 shares during the period. QRG Capital Management Inc. owned about 0.11% of Integer worth $4,895,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in ITGR. Mather Group LLC. grew its position in shares of Integer by 304.3% in the 4th quarter. Mather Group LLC. now owns 190 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 143 shares in the last quarter. Huntington National Bank lifted its stake in Integer by 8,933.3% during the third quarter. Huntington National Bank now owns 271 shares of the medical equipment provider’s stock worth $35,000 after purchasing an additional 268 shares during the last quarter. R Squared Ltd acquired a new position in Integer in the fourth quarter worth $44,000. Versant Capital Management Inc increased its stake in Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider’s stock valued at $49,000 after purchasing an additional 183 shares during the last quarter. Finally, Principal Securities Inc. raised its holdings in shares of Integer by 31.2% during the fourth quarter. Principal Securities Inc. now owns 639 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 152 shares during the period. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Trading Down 0.6 %

Integer stock opened at $123.01 on Friday. Integer Holdings Co. has a 12-month low of $107.11 and a 12-month high of $146.36. The stock has a market capitalization of $4.14 billion, a PE ratio of 36.61, a price-to-earnings-growth ratio of 1.72 and a beta of 1.13. The firm has a 50 day simple moving average of $136.85 and a 200-day simple moving average of $132.83. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Thursday, February 20th. The medical equipment provider reported $1.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.46 by ($0.03). Integer had a net margin of 6.92% and a return on equity of 11.65%. The firm had revenue of $449.50 million for the quarter, compared to the consensus estimate of $446.28 million. As a group, equities research analysts expect that Integer Holdings Co. will post 6.01 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently commented on ITGR shares. KeyCorp lifted their price target on shares of Integer from $144.00 to $154.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Truist Financial upped their target price on Integer from $147.00 to $163.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Citigroup increased their price target on Integer from $130.00 to $145.00 and gave the stock a “neutral” rating in a research report on Wednesday, December 11th. Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a research report on Friday, February 21st. Finally, Benchmark increased their target price on Integer from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Two research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $147.67.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.